Stocks and Investing Stocks and Investing
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023

Oren Livnat Maintained (zvra) at Strong Buy with Increased Target to $15 on, Dec 28th, 2023


Published on 2024-10-28 08:08:07 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $10 to $15 on, Dec 28th, 2023.

Oren has made no other calls on ZVRA in the last 4 months.



There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Oren's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Oren


  • Jonathan Aschoff of "Roth MKM" Reiterated at Strong Buy and Held Target at $25 on, Friday, October 6th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $20 on, Friday, September 1st, 2023
Contributing Sources